Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-25-000038
Filing Date
2025-01-06
Accepted
2025-01-06 16:42:15
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3318
  Complete submission text file 0000905148-25-000038.txt   5081
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Opus Genetics, Inc. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address
Bennett Jean (Reporting) CIK: 0001872219 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34079 | Film No.: 25511842